Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Gene expression markers in peripheral blood and outcome in patients with platinum‐resistant ovarian cancer: A study of the European GANNET53 consortium

International Journal of Cancer(2024)10.1002/ijc.34978Source: DataRank Database

Gene expression markers in peripheral blood and outcome in patients with platinum‐resistant ovarian cancer: A study of the European GANNET53 consortium is a research paper published in International Journal of Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.24)OA: hybridTopics (35)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Thomas Mohr ORCID,Eva Schuster,Elena Ioana Braicu ORCID,Eliane T. Taube ORCID,Jalid Sehouli ORCID

Live enrichment

PubMed:38676430 OpenAlex:https://openalex.org/W4395699455

Seventh Framework Programme

Grant: 602602

NIH National Cancer Institute

Grant: 2R01CA176647

Carol Baldwin Foundation TRO

FWCI

1.24

Citation Percentile

0.8%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.34978

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.34978

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34978

journalhttps://doi.org/10.1002/ijc.34978

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38676430

Fields of Study

Ovarian cancer diagnosis and treatmentCancer-related molecular mechanisms researchCancer Genomics and Diagnostics

MeSH Terms

AdultAgedAntineoplastic Combined Chemotherapy ProtocolsDNA-Binding ProteinsEndonucleasesFemaleHumansMiddle AgedOvarian NeoplasmsPlatinumPrognosisBiomarkers, TumorGene Expression Regulation, NeoplasticDisease ProgressionDrug Resistance, NeoplasmEstrogen Receptor alpha

Keywords

Internal medicineMedicineERCC1Odds ratioHazard ratioOvarian cancerGastroenterologyChemotherapyConfidence intervalOncologyCancerBiologyCirculating Tumor CellsHsp90 InhibitorErcc1 (Ercc Excision Repair 1 Endonuclease Non‐catalytic Subunit)Esr1 (Estrogen Receptor 1)

Sustainable Development Goals

SDG 0: Good health and well-being